Literature DB >> 12460888

Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.

Anat Bar-Shira1, Jehonathan H Pinthus, Uri Rozovsky, Myriam Goldstein, William R Sellers, Yuval Yaron, Zelig Eshhar, Avi Orr-Urtreger.   

Abstract

We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460888

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.

Authors:  Laurent Lessard; David P Labbé; Geneviève Deblois; Louis R Bégin; Serge Hardy; Anne-Marie Mes-Masson; Fred Saad; Lloyd C Trotman; Vincent Giguère; Michel L Tremblay
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

2.  Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.

Authors:  Myriam Goldstein; Isaac Meller; Josephine Issakov; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

3.  Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays.

Authors:  Sheryl R Krig; Victor X Jin; Mark C Bieda; Henriette O'Geen; Paul Yaswen; Roland Green; Peggy J Farnham
Journal:  J Biol Chem       Date:  2007-01-26       Impact factor: 5.157

4.  A microtubule-independent role for centrosomes and aurora a in nuclear envelope breakdown.

Authors:  Nathan Portier; Anjon Audhya; Paul S Maddox; Rebecca A Green; Alexander Dammermann; Arshad Desai; Karen Oegema
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

Review 5.  RBM38 in cancer: role and mechanism.

Authors:  Cheng Zou; Ying Wan; Lingjing He; Jin Hai Zheng; Yang Mei; Junfeng Shi; Min Zhang; Zhiqiang Dong; Dingxiao Zhang
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

6.  ZNF280B promotes the growth of gastric cancer in vitro and in vivo.

Authors:  Jingming Zhai; Zheng Yang; Xiaodong Cai; Guoliang Yao; Yanhui An; Wei Wang; Yonggang Fan; Chao Zeng; Kefeng Liu
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

Review 7.  Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.

Authors:  Cheng-Jeng Tai; Chung-Huei Hsu; Shing-Chuan Shen; Woan-Ruoh Lee; Ming-Chung Jiang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-11

8.  Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.

Authors:  Noa Matarasso; Anat Bar-Shira; Uri Rozovski; Serena Rosner; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

9.  Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.

Authors:  Gobi Thillainadesan; Majdina Isovic; Esther Loney; Joseph Andrews; Marc Tini; Joseph Torchia
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.